Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 9—September 2021
Research Letter

Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England

Sathyavani SubbaraoComments to Author , Helen Campbell, Sonia Ribeiro, Stephen A. Clark, Jay Lucidarme, Mary Ramsay, Ray Borrow, and Shamez LadhaniComments to Author 
Author affiliations: Public Health England, London, UK (S. Subbarao, H. Campbell, S. Ribeiro, M. Ramsay, S. Ladhani); Manchester Royal Infirmary, Manchester, UK (S.A. Clark, J. Lucidarme, R. Borrow); St. George’s University of London, London (S. Ladhani)

Main Article

Figure

Cases of invasive meningococcal disease, by academic year, England, 2015–2020. Men, meningococcal conjugate vaccine (by serogroup).

Figure. Cases of invasive meningococcal disease, by academic year, England, 2015–2020. Men, meningococcal conjugate vaccine (by serogroup).

Main Article

Page created: June 02, 2021
Page updated: August 18, 2021
Page reviewed: August 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external